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We have performed dosimetry studies using electron beams with energies up to 50 MeV,
which exceed current clinical energy ranges and approaches the bottom end of the very
high energy electron range. 50 MeV electron beams can reach deep-seated tumors. In
contrast to photon beams, electron beams can be generated with ultra-high dose rates by
linear accelerators, which could enable FLASH radiotherapy of deep-seated tumors. The
response of radiochromic film and alanine is compared with dose measurements using an
ionisation chamber. Energy dependence is not observed within the measurement
uncertainty in the investigated energy range from 15 to 50MeV.
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INTRODUCTION
Radiotherapy (RT) is a cost-effective method of treating cancer, which alone or in combination with
other cancer treatments contributes toward approximately 50% of cancer survivals [1–3]. To
improve treatment outcomes and reduce adverse side effects, new treatment modalities should
maximize tumor control, while minimizing damage to surrounding healthy tissues. FLASH
radiotherapy is a promising treatment modality [4–8], which relies on delivery of therapeutic
doses in less than a second (e.g., 90 ms [7]) at ultra-high dose rates (>40 Gy/s [4]), which are orders of
magnitude higher than currently used in conventional radiotherapy. The extremely short duration of
delivery of radiation leads to a reduction in normal tissue toxicity, while maintaining effective tumor
control (FLASH effect) [4, 6, 9–11].
Most FLASH RT studies have been conducted using electron beams from dedicated linear
accelerators with energies of 4–6 MeV [12, 13], or modified clinical linear accelerators with energies
up to 20 MeV [14, 15]. Although modified clinical linear accelerators can deliver electron beams with
ultra-high dose rates, the limited penetration depth of the clinical energy range (4–22 MeV) remains
an obstacle in FLASH RT clinical trials. The percentage depth dose (PDD) profile for 15 MeV
electrons, shown in Figure 1 as blue curve, indicates that clinical electron beams cannot reach tumors
deeper than 10 cm. This limits FLASH RT with electrons to preclinical studies using small animals
such as mice or cats [3, 9, 11] as well as human patients with superficial tumors [7] and indications
for intraoperative radiotherapy (IORT) [10].
Beams of electrons with energies exceeding the clinical energy range overcome the depth
limitation. Electrons with 100–250 MeV are known as very high energy electrons (VHEEs) [17,
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18]. They have sharp penumbra and are insensitive to tissue
inhomogeneity. In contrast to photon or proton beams, they
enable better dose conformity for some tumors located in close
proximity to tissue with varying densities, which also spares
surrounding normal tissue [18–20]. The dosimetric benefits of
VHEEs over photons have been investigated by Bazalova-Carter
et al. [18] using a treatment planning system, where they
compared VHEE treatment with clinical 6 and 15 MV state-
of-the-art volumetric modulated arc therapy (VMAT) [21]
photon plans. They reported that 100 MeV electron beams
resulted in significant sparing of organs at risk (OAR),
compared with conventional photon RT.
The majority of current radiotherapy treatments are
administered using photon radiation produced by clinical
linear accelerators. 6 MV photons, the most commonly used,
deposit their maximum dose typically over a depth of 1–2 cm
followed by an exponential decrease (see Figure 1 black dots),
resulting in lower relative dose deposition in the depth of a deep-
seated tumor (10–15 cm). However, the application of VMAT,
where the radiation dose is delivered continuously as the gantry of
the treatment machine rotates around the patient, enables dose to
be concentrated also in a deep-seated tumor while minimizing it
in the surrounding normal tissue and OAR.
The FLASH effect has been also observed with photon
radiation (from a synchrotron light source) [10], but currently
there is no method for generating ultra-high dose rate photon
beams by means of a linear accelerator for FLASH RT of deep-
seated tumors. However, 50 MeV electrons, as used in our study,
can reach deep-seated tumors situated at depths of 10–15 cm (red
curve in Figure 1). In contrast to photons, they can be generated
with ultra-high dose rates by linear accelerators. This can enable
FLASH RT also for deep-seated tumors.
Laser-driven accelerators are a promising solution for future
RT machines as they are capable of producing electron bunches
with energies from clinical to VHEE range suitable for
depositing dose at ultra-high rates [22–25]. Research is
underway to develop laser-driven accelerators for RT
applications at facilities such as the Scottish Center for the
Application of Plasma-based Accelerators (SCAPA), located at
the University of Strathclyde in the United Kingdom. A vertical
beam line utilising sub-picosecond electron bunches from a
laser-driven accelerator with energies up to 150 MeV at the
SCAPA facility is dedicated to in vitro and in vivo VHEE
studies [26].
Accurate and reliable dosimeters are required to translate
VHEE RT into the clinical stage, and also for application of
sub-picosecond electron bunches from laser-driven accelerators
used in pulsed radiolysis, laboratory astrophysics and warm dense
matter studies. Ionisation chambers (ICs), are common detectors
used in reference dosimetry for conventional external beam
radiation therapy. However, they suffer from significant ion
recombination effects when exposed to VHEE beams which
deposit the dose at ultra-high rates and/or ultra-high dose per
pulse (DPP) [27, 28]. Currently there are no dosimetry protocols
available, either for FLASH RT or VHEE, nor recommendations
for reliable dosimeters and validated methods for these novel
modalities. At present no primary standard exists that can be used
as a reference for determining the deviations of dosimeters under
such conditions.
The work presented here aims to study the energy dependence
of two passive, dose-rate independent detectors, EBT3
radiochromic film [29] and alanine [30], for application in
electron fields of up to 50 MeV. The response of the
dosimeters is compared with absolute dose measurements
performed using an ionisation chamber. The DPP is reduced
to a level where the ion recombination effect of the ionisation
chamber type used is sufficiently small and models for
quantifying the ion recombination correction are available. For
this purpose, the distance to the source was increased while
reducing the charge per beam pulse. An investigation of the
deviations due to the ion recombination effects at ultra-high DPP
as present in FLASH RT [31] and VHEE accelerators [27] is not
the focus of this work.
MATERIALS AND METHODS
Accelerator
The experiments have been carried out at the Metrological
Electron Accelerator Facility (MELAF) [32] at the German
national metrology institute Physikalisch-Technische
Bundesanstalt (PTB). The facility provides a research linear
accelerator (commissioned in 2012) for investigating dosimetry
for radiotherapy at ultra-high pulse dose rates (the FLASH RT
regime), and over a large energy range of 0.5–50 MeV. This is
considerably larger than for conventional medical accelerators,
which typically operate between 4 and 22 MeV. Furthermore, in
contrast to commercial medical accelerators, all electron beam
parameters of the PTB research accelerator are adjustable and can
FIGURE 1 | PDD profile in water for 15 MeV (blue) and 50 MeV (red)
unflattened electron beams measured in this work using an ionisation
chamber (dots) and EBT3 radiochromic film (crosses), and simulations using
FLUKA (solid curves), in addition to PDD profile of a 6 MV, 10 cm ×
10 cm photon field, measured with PTB’s clinical accelerator (black dots) and
reference data set from BJR Supplement 25 [16] (triangles).
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be measured with a high degree of accuracy. Therefore, it is
possible to study radiation effects as a function of their
fundamental physical quantities such as energy and fluence.
The research accelerator delivers pulsed electron beams with a
fixed macropulse duration of about 2.5 μs and a 3 GHz
micropulse fine structure. The term beam pulse here in the
following refers to a macropulse. The accelerator provides
controllable mean dose rates via variable pulse charge (about
1–150 nC per beam pulse) and adjustable pulse repetition
frequency (1–100 Hz). All measurements presented here are
conducted at a repetition frequency of 5 Hz. An Integrating
Current Transformer (ICT), provided by Bergoz
Instrumentation (in-flange version, windings ratio 50:1), is
included in the beamline to non-destructively measure the
charge of each electron pulse with a precision of ±0.03 nC
[33]. The minimum charge per pulse used in this work is 2 nC
and at least 100 pulses are measured to determine the charge with
a precision better than 0.15%.
The kinetic energy of the electrons can be varied continuously,
in contrast to medical accelerators where only a few fixed beam
energies can be selected. The nominal energies are varied from 15
to 50 MeV with an increment of 5 MeV. The beam energy is
measured with a magnetic spectrometer shortly before the
dosimeters are irradiated. An example of an energy
measurement is shown in Figure 2. The beams are quasi
mono-energetic with full-width at half-maximum (FWHM)
energy spread of less than 0.2 MeV. The measured actual
energies are 15.8, 19.7, 25.6, 31.1, 36.0, 41.3, 46.1, and 49.0 MeV.
The transverse beam profile and divergence are measured
using three 2d wire scanners placed at different positions along
the beam line. All beams have Gaussian transverse cross-sections
with a FWHM of about 3 mm and divergence of less than 0.1°.
Figure 3 shows a typical measured beam profile.
At the end of the beam line the electrons pass through a
0.1 mm thick Cu vacuum window which scatters the beam. The
diameter of this window was much larger (>3 cm) than the beam
width, thus all electrons detected by the ICT contributed to the
radiation field. This results in an unflattened electron radiation
field with a Gaussian shape. The beam width increases with
decreasing energy and increasing distance from the exit window.
Figure 4 shows the 2-dimensional lateral relative dose
distribution of a 40 MeV electron field recorded with an IC
matrix (PTW OCTAVIUS Detector 1500) positioned 1 m after
the exit window in air. A 1-dimensional cross section through the
central beam axis has Gaussian shape (R2 > 0.9995).
Setup
A 30 × 30 × 30 cm3 water phantom with 2 cm thick poly-methyl
methacrylate (PMMA) walls is placed with its 0.3 cm thick
PMMA entrance window in a distance of 200 cm from the
beam exit window along the central beam axis. The beam
FWHM at the entrance window of the phantom is greater
than 8 cm for all beam energies. Custom-made PMMA
holders are used to position the EBT3 films, the alanine pellets
and the IC inside the water phantom. A 3-dimensional precision
motorized positioning system allows i) to place the dosimeters at
a certain depth along the central beam axis, ii) to perform
controlled longitudinal movement of the IC along the central
beam axis for depth dose measurements, and iii) to perform
controlled lateral movements to determine the cross-sectional
dose distribution of the radiation field. Figure 5 shows a
photograph of the water phantom with the positioning
systems in front of the beam line.
The dosimeters are irradiated successively at the same position
to ensure they receive equal dose and are irradiated with identical
dose gradient within the radiation field. The beam pulse charge
measured by the ICT is used as reference for successive
irradiation of the different dosimeters, because the charge is
proportional to the dose. Two ICs (Wellhöfer IC10) are
mounted in the water phantom at the depth of the respective
dosimeter under investigation, about 10 cm left and right from
the central beam axis. They are used as radiation monitors to
verify the ICT signal. The ratio of the signals from both radiation
monitor ICs is used to verify that the maximum of the radiation
field does not change its position over time. Figure 6 shows the
typical response of one of the radiation monitor chambers in the
water phantom as function of the signal from the ICT beam
current monitor during an irradiation. The typical pulse-to-pulse
charge fluctuations (<3%) are proportional to the dose response
from the radiation monitor.
Dosimeters
Ionisation chamber
A parallel-plate Advanced Markus IC (PTW 34045, s/n:1279) is
used to determine the absorbed dose to waterDw. The signal from
the IC is read out using an analogue electrometer (Keithley 616)
in current mode. The reading, M, of the analogue electrometer is
recorded using a 16-bit analogue-to-digital-converter and
analysed using custom software. A calibrated current source
(Keithley 6430) is used to calibrate the electrometer with its
own read-out system. The Advanced Markus chamber is
calibrated using PTB’s Co-60 reference field in terms of
absorbed dose to water, which is traceable to the PTB’s
primary standard water calorimeter [34].
For absolute dose measurements the signal of the Advanced
Markus chamber is converted to absorbed dose to water, Dw,
following the German protocol DIN 6800-2 recommendations
[35] for dosimetry in conventional radiotherapy:
Dw  N ′Co60 , Dw · (M −M0) · kE · kS · kP · kT,p, (1)
where N′Co60, Dw is the calibration factor of the chamber with
respect to Co-60 radiation, M is the reading of the dosimeter
corrected for the reading without irradiationM0, kE is the quality
correction factor accounting for the difference in detector’s
response between Co-60 radiation and high-energy electron
radiation, and kS is the correction factor for ion
recombination. The factors kP and kT,p take into account the
effects of polarity and the ambient conditions, respectively. The
reference conditions, procedures and the approximation
formulas in the DIN 6800-2 [35] are consistent with those in
IAEA’s Code of Practice (CoP) TRS398 [36, 37].
The radiation quality correction factor kE in Eq. 1 is the
product of a chamber design dependent constant kE″ and a
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chamber independent function k′E, which is essentially the energy
dependent stopping power ratio. According to DIN 6800-2 [35]
kE″ for the Advance Markus chamber is equal to 0.985. At the
reference depth, zref, the value k′E is calculated using the following
equation:
k′E  1.106 − 0.1312 · (R50)0.214, (2)
where the half-value depth, i.e., the depth at which the absorbed
dose is dropped to 50% of its maximum value, R50, of the energy
dependent depth dose distribution is given in cm. Equation 2 is
valid only for the measurements at the reference depth, zref, which
is determined by:
zref  0.6 · R50 − 0.1, (3)
where R50 and zref are expressed in cm. R50 must be determined
experimentally for each energy from the half-value depth of the
ionisation current depth curve R50,Ion, i.e., the half-value depth of
the chamber signal as a function of the depth in water, by
R50  1.029 · R50, Ion − 0.06 cm for R50, Ion ≤ 10 cm, (4)
R50  1.059 · R50, Ion − 0.37 cm for R50, Ion > 10 cm. (5)
The ion recombination correction factor, kS, in Eq. 1 depends on
the DPP and the applied chamber voltage U. In this work kS is
determined using two methods. The method recommended in
DIN 6800-2 [35] is to obtain ks from Jaffé plots. This is described
and investigated for many types of ionisation chambers in DPP
ranging from 0.15 to 42 mGy/pulse [35, 38]. For a Jaffé plot U is
gradually changed during irradiation while the associated IC
reading M(U) is recorded and then 1/M(U) is plotted versus
1/U. If the obtained Jaffé plot is linear, then the ionisation
chamber reading at infinite chamber voltage can be
determined by linear extrapolation to 1/U  0. If the Jaffé plot
is normalized to the reading at chambers operating voltage the
y-intercept of the linear fit is equal to kS. In this work, the voltage
of the chamber, irradiated at zref, is changed gradually from
chamber’s operating voltage 300–20 V for different DPP values in
the range of 10–40 mGy/pulse in order to determine ks from
Jaffé plots.
The high DPP range (20–120 mGy/pulse) delivered by linear
accelerators in IORT is comparable to the DPP range used in
this work. Extensive studies have been carried out on ion
recombination effects of ICs for high DPP beams [39–42]. A
method of determining kS for high DPP ranges without using a
dose reference has been introduced by Laitano et al. [39]. This
approach takes into account free electrons produced in the
chamber, which are collected by the anode without being
attached to oxygen molecules, described by three different
models proposed by Boag et al. [43]. This approach has been
applied by Pimpinella et al. [42] with the assumption that the
third Boag’s model provides the best description. The approach
of Laitano et al. [39] with the third Boag’s model is used in this
work as second method for ks determination. The free-electron
fraction p is calculated according to Laitano et al. [39] for the
Advanced Markus chamber to yield p  0.6855. Then numerical
calculations using formula A.3 in the appendix of Ref. 39 are
carried out.
The polarity effect of the Advanced Markus chamber has been
investigated for clinical electron beams by Pearce et al. [44] who
observed a large polarity correction effect for lower energy clinical
beams (≈4 MeV). However, with increase in energy the
correction due to polarity diminished, which for 9 MeV is
0.48%. In this work kp  1 is assumed and an uncertainty of
0.5% is assigned. The correction factor kT,P has been calculated
from pressure and temperature measured during IC exposures
and found to be between −0.3 and +0.6 %.
To determine the dose at a depth other than zref an additional
correction factor kNR, E must be included in Eq. 2. The PDD in
Figure 1 results from the signal of the Advance Markus chamber
FIGURE 2 | Example of an energy measurement using the magnetic
spectrometer. A Gauss function is fitted to the upper part to half maximum to
determine the peak position and width.
FIGURE 3 | Vertical beam profile obtained for 50 MeV nominal energy
with a wire scanner.
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after the conversion to a dose by taking into account kNR, E
according to DIN 6800-2 [35].
Alanine
The alanine pellets are produced with diameter of 5 and 3 mm
height. The pellets are arranged in stacks of 8 pellets to form a
cylinder. The alanine stacks are positioned within a PMMA tube
at zref with the longer dimension perpendicular to the beam
central axis. Their response is temperature dependent (0.18%/°C)
[45]. To account for this dependence, and to ensure that the
pellets are at thermal equilibrium with their environment, the
temperature of the water is recorded, and irradiation not
commenced until the pellets have been immersed for about
10 min. At each energy an alanine stack is irradiated with a
nominal dose of 15 Gy while the charge of the electron beam
pulses was simultaneously measured. Uncertainties of 0.4–0.6%
(k  1) are reached at Co-60 radiation for irradiations in the range
of 5–25 Gy [46]. For the conversion of the alanine’s response to
electron radiation an additional radiation quality correction
factor kE
ala has to be applied. This factor is known with an
uncertainty of 1 % for electron energies up to 22 MeV [47]. A
detailed description of PTB’s alanine dosimetry system and
readout of the irradiated pellets can be found elsewhere [46–49].
GafChromic™ EBT3 films
GafChromic™ EBT3 films (www.gafchromic.com) from lot
#06141702 (chemical composition provided in Supplementary
Table S1) are used to measure the dose absorbed to water. The
films are placed at zref and exposed to 6 dose levels between 5 and
20 Gy for all electron energies, while keeping all other beam
settings fixed. The doses are delivered by varying the number of
beam pulses in the range of 140–1600. The pulse charge is
recorded with the ICT.
Stacks of equispaced films in a dedicated holder, as shown in
Figure 7, are used to measure PDD profiles for all energies. All
films in the stack together are 0.28 cm thick. The water equivalent
thickness of the whole stack is about 0.3 cm. The measured PDD
profiles are compared with those obtained with the IC and Monte
Carlo (MC) simulations.
All films are scanned one week after irradiation to avoid
differences in film self-development after exposure [50]. A
multichannel flatbed EPSON Expression 10000XL Pro scanner
is used to record the digital image of each film. All films are
scanned in the same orientation to avoid variations in optical
properties due to scanning orientation [51]. Images are measured
in transmission using the RGB-positive mode at a depth of 16 bits
per color channel with a spatial resolution of 127 dpi, which
corresponds to a pixel size of 0.2 mm × 0.2 mm. Images are saved
in TIFF format and analysed using a python script, following the
protocol described by Devic et al. [50]. A single unexposed piece
FIGURE 4 | 2-dimensional dose distribution of 40 MeV electron beam in
air captured with an ionisation chamber matrix (PTW OCTAVIUS 1500) 1 m
from the exit window.
FIGURE 5 | Photograph of the setup. Water phantom inside the frame of
the 3D positioning system in front of the accelerator beam line.
FIGURE 6 | Typical response of the radiation monitor chamber in the water
phantom as function of the beam pulse charge measured with the ICT.
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of film, which is kept together with the exposed films, is used as a
control. A Wiener filter is applied to the irradiated and control
film images.
A region of interest (ROI) of 25 × 25 pixels (5 × 5 mm2) is
selected from the central area of the film, which is
comparable with the cross-section of the sensitive volume
of the Advanced Markus chamber (5 mm in diameter). The
average pixel value (PV) within the ROI is used to calculate
the net optical density (netOD), which is the change in
optical density before and after irradiation, given by
netOD  log10(PVbefore/PVafter). Absolute response is
determined using the green color channel, which is
preferable for doses up to 40 Gy [52, 53].
Calibration of the EBT3 film has been performed at NPL
with 12 MeV electron beams and a dose rate of 600 cGy/min
using a clinical linear accelerator (Elekta Synergy). To avoid
variations due to different lot numbers, film from the same
batch is used for both the measurements at PTB and calibration
at NPL. The irradiation is performed in a 30 × 30 × 30 cm3
solid-water phantom at 5 different dose levels between 1 and
20 Gy under reference conditions (source-to-surface distance
of 100 cm and 20 × 20 cm2 field size) at zref  2.8 cm. The dose
delivered to each film have been established based on the output
measurements at reference conditions using a Roos IC (PTW
34001), which has been traceably calibrated in terms of Dw to
NPL’s primary standard graphite calorimeter [54]. The dose is
determined from the netOD values and the dose-response
calibration curve is fitted using the following analytical
function:
D  a · netOD + b · netODn, (6)
where a, b and n are fit parameters.
Monte Carlo Simulation
Simulations have been carried out using the FLUKA MC code
(FLUKA2011 Version 2x.7) [55, 56] with 107 particles and 10
cycles. The physics settings are described in the FLUKA manual
under the physics package PRECISIOn. The photonuclear
reactions are activated by the card PHOTONUC. The
threshold for transport and production of δ-particles and
photons (ECUT, PCUT) is set to 10 keV.
In the model, a monoenergetic parallel beam with a Gaussian
cross-section (3 mm FWHM) is scattered by the 0.1 mm thick Cu
foil of the vacuum exit window at the end of the beam line. The
incident electron beam parameters are measured (see section
Accelerator). The electrons propagate in air from the source (exit
window) to the phantom.
The dose distribution in water is simulated by a 30 × 30 ×
30 cm3 water cube defined with a FLUKA USRBIN mesh that has
a resolution of 0.065 cm. The on-axis dose is calculated within a
0.5 × 0.5 × 30 cm3 rectangular volume around the central
beam axis.
RESULTS AND DISCUSSION
EBT3 Film Calibration
The red crosses in Figure 8 shows the reference dose applied to
the EBT3 films at NPL as a function of the resulting netOD value
obtained from the respective film. The data points are fitted to the
analytical function given in Eq. 6 (red curve).
The radiation quality correction factor kE
ala to correct
alanine’s response for electron radiation is known up to
22 MeV [47]. The alanine dose measurements for 15 and
20 MeV can therefore be traced to the PTB’s primary
standard. They can, in turn, be used to calibrate EBT3 film
irradiated under the same conditions. For comparison, the
doses determined using alanine for 15 and 20 MeV are plotted
as function of the corresponding netOD values in Figure 8 as
open circles and squares, respectively. The resulting dose-
response calibration curve from a fit to Eq. 6 is also shown. It
is similar to the NPL’s calibration curve. In the studied dose range
of 5–20 Gy the resulting dose difference between NPL and PTB
calibration can vary from −1% up to 4%. The dose values
determined with EBT3 in this work are based on the NPL
calibration function.
Ion Recombination Correction for the
Advanced Markus Ionisation Chamber
Themean dose rates used in this investigation vary between 3 and
12 Gy/min, which is within the range of conventional
radiotherapy. However, the DPP, ranging from 10 mGy to
40 mGy per pulse, is significantly higher than for a medical
accelerator (0.1–3 mGy per pulse) and comparable with that
used in IORT, where non-negligible ion recombination effects
have been reported [39, 40, 42, 57, 58]. Two approaches for
evaluation of a kS factors i) the Jaffé plots and ii) the method
described by Laitano et al. [39] (described in section Ionisation
Chamber) were applied and compared against each other.
FIGURE 7 | Stack of equispaced EBT3 films in a dedicated holder after
exposure to electron beam.
Frontiers in Physics | www.frontiersin.org November 2020 | Volume 8 | Article 5683026
Kokurewicz et al. Dosimetry for High Energy Electrons
Figure 9 shows Jaffé plots for the lower and upper edge of the
studied DPP range. The y-intercept (1/ks) of the linear fits is 0.98
and 0.94, respectively, yielding kS of 1.02 and 1.06. These ion
recombination correction factors are significantly higher than in
conventional RT (typically <1.01).
The open circles in Figure 10 represents kS factors determined
using the Jaffé plots approach. The dashed red line represents the
ks function given by Bruggmoser et al. [38]
kS  1 + (0.43 + 0.49 · Dw,pulse)/U , where Dw, pulse is the DPP
expressed in mGy and U is the chamber voltage expressed in V,
for U  300 V in the experimentally determined DPP range up
to 5.5 mGy/pulse. This function is recommended for the
Advanced Markus chamber in the DIN 6800-2 [35]
protocol. The red solid line is the extrapolation to the high
DPP investigated here. There’s no indication of any inaccuracy
in determination of ion recombination factor by Jaffé plots
because the plots shown in Figure 9 are well represented by
linear fits. Moreover, the extrapolation of Bruggmosers
function is also in good agreement with the determined ks
values (Figure 10). However, Laitano et al. [39] pointed out
that the observed linearity in Jaffé plots may motivate one to
perform a zero linear extrapolation to find the factor ks even in
conditions of high DPP and that this can lead to considerably
inaccurate determination of ks (up to 40%). The blue squares
in Figure 10 represent the results obtained employing
Laitano’s approach using the same data as for the Jaffé
plots. The function, that represents best fit to the series of
data points kS  0.00026 mGy− 1 · DW + 1.0003. After
comparing both methods, it was found that the ks factors
determined by Jaffé plots yield 1.5–5% higher values in the
used DPP range.
For comparison, the results from an experimental
determination of ks from Cella et al. [40] are also shown in
Figure 10. These were determined by comparing the dose
determined with an Advanced Markus chamber without
taking into account any recombination effects against a
reference dose determined with Fricke dosimeters, i.e., no
theoretical assumptions were needed. In the relevant DDP
range these values are about 0.3–1.5% larger than the results
from this work using Laitano’s approach.
FIGURE 9 | Jaffé plots: reciprocal readings 1/M of the Advance Markus
chamber as function of the reciprocal chamber voltages 1/U, normalized to
the reading at 300 V for 10 mGy/pulse (blue circles) and 40 mGy/pulse (red
circles), respectively. Solid lines represent linear fits to the data points.
FIGURE 10 | kS factor as a function of dose per pulse determined for the
AdvancedMarkus chamber at 300 V operating voltage using Jaffé plots (open
circles) and approach from Laitano et al. [39] (open squares). For comparison,
the kS function fromBruggmoser et al. [38], recommend in the DIN 6800-
2 protocol, is shown in the range where determined experimentally (dashed
red line) and extrapolated to the high DPP range used in the current
experiment (solid red line). Also shown are the results from an experimental
determination by Cella et al. [40] using a Fricke dosimeter as reference. Lines:
linear fits.
FIGURE 8 | Reference dose applied to the EBT3 films at NPL plotted
against the resulting netOD values from the green channel (red crosses). Also
shown are the doses applied to the EBT3 films at PTB, measured with alanine,
at 15 and 20 MeV, respectively (open circles and squares, respectively).
The solid and dashed lines represent fits using Eq. 6.
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Comparison of Different Methods for
Relative Dose Measurements
Figure 1 shows relative depth dose curves measured with the IC
and EBT3 films for 15 and 50 MeV electron beams produced by
the PTB research accelerator using the experimental setup
described in Setup. The measurements have been compared
with Monte Carlo calculations carried out using FLUKA,
which incorporates an accurate physics model of electron
interactions with matter within the investigated energy range.
The ion chamber measurements for the 50 MeV beam are in
excellent agreement with the MC simulations. However, some
discrepancy exists between measured and calculated data for the
15 MeV beam at 1–3 cm. The PDDmeasured at discrete positions
with EBT3 films is significantly more scattered compared to the
IC measurement due to substantial uncertainties associated with
this detector, which can easily reach 5% [52]. They vary between
+3 and −9% with respect to the PDD measured with the IC.
The radiation field at the depth of the detectors is not
homogenous, in particular at higher energies. Therefore, the
relative dose distributions in lateral directions are recorded for
each energy at two different depths to determine the exact
position of the beam central axis at dose maximum. Figure 11
shows lateral dose distributions for the two extremes of the
electron energy range used in this study and thus the
narrowest and broadest radiation field used at PTB.
The variations in dose within the sensitive volume of the
Advanced Markus Chamber (±2.5 mm from the beam axis,
marked in Figure 11) is less than 0.5%, even for the narrowest
radiation field (50 MeV). This indicates that on the beam axis the
deviation due to non-uniform radiation fields is negligible. The
data points from the stack of 8 alanine pellets (green crosses) are
consistent with the IC results. The data points from the
radiochromic film (open diamonds) scatters more than IC and
alanine data but represent well the lateral profile.
Figure 12 shows R50 measured as function of electron energy.
The relative depth dose profiles have been measured and
calculated for all beam energies. The agreement between the
FLUKA simulations and IC measurements, shown in Figures 1
and 12, indicate that the dosimetry procedures recommended by
DIN6800-2 for homogeneous fields are also applicable to
unflattened radiation fields, as investigated in this work.
R50 depends on the energy and the field size. For comparison, the
R50 values established in this study are plotted in Figure 12 together
with the R50 values determined for 20 × 20 cm2 and 4 × 4 cm2 fields.
The R50 of the used unflattened Gaussian shaped field is in between
the R50 values of the small and the large flat fields. With increasing
energy, the width of the radiation field becomes smaller and thus R50
tends to the extrapolated line for the smaller field.
Comparison of Different Methods for
Absolute Dose Measurements
None of the three dose measurement methods can serve as a
reference because one cannot rule out effects due to non-standard
radiation fields. Therefore, the three dosimetry methods can only
be compared against each other. Figure 13 shows the dose at zref
per unit charge measured by the ICT, for the three different
dosimeters as a function of electron beam energy. The dose rises
with increase in energy. The slope increases because the width of
the radiation field decreases with increasing energy and thus a
larger fraction of the beam electrons deposits energy close to the
central beam axis. A least square fit of a 2nd order polynomial
function is fitted to all data points of the three dosimeters to
FIGURE 11 | The lateral dose profiles for 15 and 50 MeV at 30 mm
depth in water as well as for 50 MeV at 150 mm depth measured with the
ionisation chamber (solid symbols). Also shown are the results of EBT3 films in
5 mm steps (open diamonds), and the stack of 8 alanine pellets (green
crosses) for 50 MeV at 96 mm depth. Solid lines represent Gaussian fits to the
data points. The vertical bar indicates the position and size of the sensitive
volume of the Advanced Markus chamber (5 mm).
FIGURE 12 | R50 plotted as function of the energy, measured with the IC
(red crosses) and calculated using FLUKA (blue dots) for the inhomogeneous
field. The reference data from BJR Supplement 25 [16] for homogeneous
radiation fields with 20 × 20 cm2 (triangles) and 4 × 4 cm2 (squares) field
sizes are included for comparison. Dashed lines represent linear
extrapolations to higher energies.
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evaluate deviations of each point from the common trend.
Figure 14 shows the percentage deviation (for the three types
of detectors) from the fit function.
The response of EBT3 films has been averaged over 6
measurements (gray dots) carried out for doses in the range
5–20 Gy. The data points for single films are scattered within
several percent (max. 9%) around the common mean value for all
dosimeters (Zero line in Figure 14). The deviation (σ  3.7%) is
not correlated with the delivered dose or beam energy. The mean
values of the 6 measurements (crosses) agree with the mean of the
alanine and IC results to within 3%. No energy dependence is
observed within the uncertainty.
The dose at the central beam axis from the dose measurements
with the stack of 8 alanine pellets is obtained as the maximum of a
Gaussian fit to the 8 doses captured along the lateral beam profile
(see green crosses in Figure 11). The blue squares in Figure 14
represent the percentage deviation of the alanine dosimeter
measurements from the common trend. The relative uncertainty
was estimated to 1.1% (k  1). The main contribution is the
uncertainty in the radiation quality correction factor kE
ala (1%)
[47]. No beam quality dependence is observed within investigated
energy range. This indicates that the assumption that kE
ala is
constant, as it is at lower energies [47], is adequate. A systematic
shift of 1.9% on average can be observed, with respect to the results
from the IC evaluated using ks from Laitano’s approach (open circles
in Figure 14). This may indicate that this ks is too small. If the fit
function to the results of Cella et al. [40] (dotted line in Figure 10) is
used, then themean deviation is about 0.9%. The relative uncertainty
of the IC measurements is estimated to be 1.5%. Therefore, the
average shift is within the uncertainties. However, the variation in
the difference between IC and alanine results (0.4% at 40MeV, 3.8%
at 50MeV) cannot explained by the considered uncertainty
contributions: the uncertainty of alanine without the contribution
of the constant kE
ala is only 0.4% and the approximations that
introduce an uncertainty when converting the IC signal into a dose
are smooth functions of energy. Approaches taking into account the
free electrons at determination of ks are associated with large
uncertainty [39] but IC measurements with different DPP are
consistent with each other (multiple data points for IC at each
energy in Figure 14). Due to the relatively large scattering of the
difference between alanine and IC measurement it is not possible to
make a conclusion about whether Laitano’s approach is correct.
Further investigations with lower measurement uncertainty are
planned to reveal the cause of the systematic difference between
IC and alanine dose determination and its variation.
Neither the DIN 6800-2 [35] nor the TRS398 [36] protocol
provide recommendations for high DPP beams, or mention limits
due to effects of the free electron fraction in determining ks.
Petersson et al. [31] reported up to 75% ion collection losses due
to recombination effects for ultra-high DPP beams in FLASH RT
(hundreds of mGy/pulse to few Gy/pulse). The data presented in
the published literature [39, 42, 57, 58] and in this work indicates
that there is a strong need to develop a clear dosimetry guidance
to support accurate dosimetry of high and ultra-high DPP beams.
CONCLUSION
Three different dosimetry methods, including EBT3 radiochromic
film, ionisation chamber, and alanine, have been investigated for
electron beams with energies exceeding the clinical range up to
50MeV in support of future studies of VHEE radiotherapy, and
FLASH radiotherapy with VHEE beams.
All three methods provide similar results for relative
dosimetry (depth dose curve, lateral dose profile). However,
results from the EBT3 film has a variance of several percent,
when compared with IC and alanine measurements. The half-
value depth of measured percentage depth dose profiles of the
unflattened radiation fields agrees well with MC simulations. This
indicates that the dosimetry procedures for homogeneous fields are
also applicable to unflattened radiation fields.
FIGURE 14 | Deviation of the dose response for EBT3 films (green
channel), alanine and IC, from the fit curve shown in Figure 13.
FIGURE 13 | Dose per unit charge measured with EBT3 film (crosses),
alanine (squares), and ionisation chamber (circles) at the reference depth.
Dashed curve represents 2nd order polynomial fit to all data points.
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The ion recombination correction factor for the Advanced
Markus IC is determined with an approach which considers free
electrons. Comparing this approach with the results from Jaffé
plots it is found that the latter yields 1.5–5% higher values for the
high dose-per-pulse range.
The absolute dose measurements of the three methods have been
compared against each other. For all beam energies single EBT3 film
measurements show relatively high percentage deviations (up to 9%)
over the dose range independent of the delivered dose. However, the
mean values of 6measurements agree well with themean of the dose
values from IC and alanine (mean deviation 1.2%, maximum
deviation 3%). No energy dependence is observed within the
uncertainty in the investigated energy range up to 50MeV.
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